Last reviewed · How we verify
Pharmacological Treatment
Pharmacological Treatment is a Pharmacological treatment Small molecule drug developed by University of Louisville. It is currently FDA-approved for Pain management, Inflammation reduction. Also known as: Ibuprofen (400 mg), control group, Conventional pharmacological treatment.
Pharmacological treatment works by modulating the body's response to a specific disease process.
Pharmacological treatment works by modulating the body's response to a specific disease process. Used for Pain management, Inflammation reduction.
At a glance
| Generic name | Pharmacological Treatment |
|---|---|
| Also known as | Ibuprofen (400 mg), control group, Conventional pharmacological treatment |
| Sponsor | University of Louisville |
| Drug class | Pharmacological treatment |
| Modality | Small molecule |
| Therapeutic area | General medicine |
| Phase | FDA-approved |
Mechanism of action
It achieves this by interacting with the body's natural systems to produce a therapeutic effect. The exact mechanism can vary depending on the specific disease being treated.
Approved indications
- Pain management
- Inflammation reduction
Common side effects
- Nausea
- Headache
- Dizziness
Key clinical trials
- A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC) (PHASE2)
- Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers (PHASE3)
- Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer (PHASE1)
- Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma (PHASE1)
- Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial (PHASE2)
- Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (PHASE3)
- A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) (PHASE3)
- Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pharmacological Treatment CI brief — competitive landscape report
- Pharmacological Treatment updates RSS · CI watch RSS
- University of Louisville portfolio CI
Frequently asked questions about Pharmacological Treatment
What is Pharmacological Treatment?
How does Pharmacological Treatment work?
What is Pharmacological Treatment used for?
Who makes Pharmacological Treatment?
Is Pharmacological Treatment also known as anything else?
What drug class is Pharmacological Treatment in?
What development phase is Pharmacological Treatment in?
What are the side effects of Pharmacological Treatment?
Related
- Drug class: All Pharmacological treatment drugs
- Manufacturer: University of Louisville — full pipeline
- Therapeutic area: All drugs in General medicine
- Indication: Drugs for Pain management
- Indication: Drugs for Inflammation reduction
- Also known as: Ibuprofen (400 mg), control group, Conventional pharmacological treatment
- Compare: Pharmacological Treatment vs similar drugs
- Pricing: Pharmacological Treatment cost, discount & access